Back

Early initiation of antiplatelet therapy - Recommendations and current practice.

logo

Session: Antiplatelet therapy in high-risk patients with acute coronary syndromes – Current evidence and future directions
Topic: Thrombosis and platelets
Speaker: Professor P. Steg (Paris, FR)
Organised by The Sahlgrenska Academy - Goteborg University / Course Director: Karl Swedberg / Supported by an unrestricted educational grant from AstraZeneca
Event: ESC CONGRESS 2014

About the speaker

Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)
63 presentations
10 followers

7 more presentations in this session

Introduction and objectives - Antiplatelet therapy in high-risk patients with ACS.

Speaker: Doctor A. Fernandez Ortiz (Madrid, ES)

Access
Slides
Thumbnail

Discussion - Early initiation of antiplatelet therapy.

Access
Thumbnail

Thienopyridines and ticagrelor – New pharmacological evidence and clinical effects.

Speaker: Professor R. Storey (Sheffield, GB)

Access
Slides
Thumbnail

Discussion - Thienopyridines and ticagrelor.

Access
Thumbnail

Optimising duration of antiplatelet therapy following acute coronary syndrome.

Speaker: Professor P. Serruys (Galway, IE)

Access
Slides
Thumbnail

Access the full session

Antiplatelet therapy in high-risk patients with acute coronary syndromes – Current evidence and future directions

Speakers: Professor P. Steg, Doctor A. Fernandez Ortiz, Professor R. Storey, Professor P. Serruys
Access
Thumbnail

About the event

Image

ESC CONGRESS 2014

30 August - 3 September 2014

Sessions Presentations

logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb